SHINYA YAMAMOTO to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications SHINYA YAMAMOTO has written about Antineoplastic Agents, Immunological.
Connection Strength
0.246
-
Population pharmacokinetic analysis of bevacizumab in Japanese cancer patients with proteinuria: a prospective cohort study. Cancer Chemother Pharmacol. 2025 Mar 21; 95(1):46.
Score: 0.199
-
Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series. Cancer Chemother Pharmacol. 2024 10; 94(4):615-622.
Score: 0.046